1. Home
  2. MDBH vs VERU Comparison

MDBH vs VERU Comparison

Compare MDBH & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.65

Market Cap

35.0M

Sector

N/A

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.42

Market Cap

39.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
VERU
Founded
1997
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0M
39.8M
IPO Year
2023
1990

Fundamental Metrics

Financial Performance
Metric
MDBH
VERU
Price
$3.65
$2.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$25.00
AVG Volume (30 Days)
11.0K
122.9K
Earning Date
11-13-2025
12-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$1,250,398.00
$16,886,419.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.63
N/A
Revenue Growth
N/A
337.24
52 Week Low
$3.16
$2.11
52 Week High
$7.98
$14.20

Technical Indicators

Market Signals
Indicator
MDBH
VERU
Relative Strength Index (RSI) 44.65 39.28
Support Level $3.30 $2.33
Resistance Level $3.69 $2.51
Average True Range (ATR) 0.22 0.18
MACD 0.01 0.05
Stochastic Oscillator 27.12 58.68

Price Performance

Historical Comparison
MDBH
VERU

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: